{"nct_id":"NCT04052997","title":"Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patients With Relapsed or Refractory Hodgkin Lymphoma","status":"COMPLETED","status_verified_date":"2024-03","start_date":"2019-09-13","start_date_type":"ACTUAL","primary_completion_date":"2023-01-19","primary_completion_date_type":"ACTUAL","completion_date":"2023-01-19","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["ADCT"]}